Stock 6554 CROWN BIOSCIENCE INTERNATIONAL
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Crown Bioscience International

Equities

6554

KYG2568J1013

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
- TWD - Intraday chart for Crown Bioscience International

Managers

Managers TitleAgeSince
Armin Spura CEO
 Chief Executive Officer - 20-03-31
Jean-Pierre Wery CHM
 Chairman - 08-06-30

Members of the board

Members of the board TitleAgeSince
Jean-Pierre Wery CHM
 Chairman - 08-06-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 145,314,390 91,522,390 ( 62.98 %) 0 62.98 %

Company contact information

Crown Bioscience International

Room No. 1705, 17th Floor No. 333, Section 1, Keelung Road

110 12, Taipei

+

address Crown Bioscience International(6554)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+39.20% 50.93B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.29% 42.12B
LONZA GROUP AG Stock Lonza Group AG
+49.62% 42.05B
CELLTRION, INC. Stock Celltrion, Inc.
-7.20% 29.18B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.07% 26.02B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.36% 18.9B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.31% 13.21B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.64% 12.17B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.15% 12.16B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 6554 Stock
  4. Company Crown Bioscience International
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW